Baidu
map

Int Arch Occup Environ Health:在幼儿园工作能够增加听力相关症状的风险

2019-07-26 AlexYang MedSci原创

最近,有研究人员评估了是否在幼儿园工作能够增加听力相关症状的风险,以及是否年龄、职业噪音和压力工作条件能够影响上述风险。研究包括了4718名幼儿园教师和4122名随机挑选的对照。他们的年龄在24-65岁。研究人员通过调查问卷的方式对听力损失、耳鸣、语言感知困难和听觉疲劳等听力相关的症状进行了调查。研究发现,与对照相比,幼儿园教师的声音诱导的听觉疲劳(RR 2.4, 95%CI 2.2-2.5)和听

最近,有研究人员评估了是否在幼儿园工作能够增加听力相关症状的风险,以及是否年龄、职业噪音和压力工作条件能够影响上述风险。

研究包括了4718名幼儿园教师和4122名随机挑选的对照。他们的年龄在24-65岁。研究人员通过调查问卷的方式对听力损失、耳鸣、语言感知困难和听觉疲劳等听力相关的症状进行了调查。研究发现,与对照相比,幼儿园教师的声音诱导的听觉疲劳(RR 2.4, 95%CI 2.2-2.5)和听觉过敏(RR 2.3, 2.1-2.5)的患病率与风险比(RR)超过了2倍,且语言感知困难方面接近2倍(RR 1.9, 1.7-2.0)。另外,幼儿园教师的听觉过敏的发病率和发病率比率(IRR)是对照的3倍,而语言感知困难方面多于2倍(IRR 2.4, 2.2-2.6)。在听力损失和耳鸣患者中,虽然RR和IRR的提升幅度小,但仍具有显著性差异。当根据年龄和职业接触噪音和压力进行分层后,幼儿园教师的RR和IRR仍增加。

最后,研究人员指出,他们的研究表明了幼儿园里工作能够增加自我报道的听力相关症状的风险,且很有必要采取预防措施。

原始出处:

Fredriksson S, Kim JL, Torén K et al. Working in preschool increases the risk of hearing-related symptoms: a cohort study among Swedish women. Int Arch Occup Environ Health. 8 Jul 2019

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1861332, encodeId=0b331861332e9, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Thu Jun 25 10:25:00 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306402, encodeId=6ff3130640237, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353103, encodeId=01d21353103be, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524287, encodeId=e800152428eb7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621810, encodeId=c15916218107c, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]
    2020-06-25 shizhenshan
  2. [GetPortalCommentsPageByObjectIdResponse(id=1861332, encodeId=0b331861332e9, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Thu Jun 25 10:25:00 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306402, encodeId=6ff3130640237, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353103, encodeId=01d21353103be, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524287, encodeId=e800152428eb7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621810, encodeId=c15916218107c, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]
    2019-07-28 ysjykql
  3. [GetPortalCommentsPageByObjectIdResponse(id=1861332, encodeId=0b331861332e9, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Thu Jun 25 10:25:00 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306402, encodeId=6ff3130640237, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353103, encodeId=01d21353103be, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524287, encodeId=e800152428eb7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621810, encodeId=c15916218107c, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]
    2019-07-28 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1861332, encodeId=0b331861332e9, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Thu Jun 25 10:25:00 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306402, encodeId=6ff3130640237, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353103, encodeId=01d21353103be, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524287, encodeId=e800152428eb7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621810, encodeId=c15916218107c, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]
    2019-07-28 july_979
  5. [GetPortalCommentsPageByObjectIdResponse(id=1861332, encodeId=0b331861332e9, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Thu Jun 25 10:25:00 CST 2020, time=2020-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306402, encodeId=6ff3130640237, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353103, encodeId=01d21353103be, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524287, encodeId=e800152428eb7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621810, encodeId=c15916218107c, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 28 04:25:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]

相关资讯

JAMA Otolaryngol Head Neck Surg:中年听力损失与晚期颞叶体积损失相关

中年时期(45-65岁)的听力损伤(HI)可能与颞叶结构的纵向神经退行性变有关,该退行性变化是早期阿兹海默症的生物标记。最近,有研究人员评估了中年时期HI与老年时期(不小于65岁)大脑容量轨迹的相关性。研究总共包括了194名患者(平均年龄54.5(10.0)岁;106名女性;169名为白种人)。在邦费罗尼校正后,研究人员发现,在较好耳朵中中年时期不良听力与老年时期右侧颞灰质体(β=-0.113;

Otol Neurotol:卵圆窗耳蜗移植后前庭功能和听力保留情况研究

最近,有研究人员调查了耳蜗移植后短期残余听力丧失与前庭功能之间可能的关系。研究是一个回顾性的患者检查。研究包括了120在热力测试中具有正常前庭功能(VF)的患者,且在手术侧250、500和1000?Hz时具有残余听力(RH)。研究的时间在2008年到2016年之间。研究人员分析了术后RH和VF7的变化,并在250、500和1000Hz进行了纯音听觉测定,利用测量的术后阈值来确定RH的保留情况。另外

JAMA Otolaryngol Head Neck Surg:突发神经性听力损失的高压氧治疗和药物治疗比较

突发神经性听力损失(SSNHL)在72小时内发生,并且在3个或者更多的连续频率中至少为30dB。尽管类固醇治疗是有益的,但仍旧需要额外的治疗。最近,一些系统性的回顾评估了在SSNHL患者中高压氧治疗(HBO)与恢复效果之间的相关性。研究指出,这些系统性的回顾阐释了HBO可能为传统的皮质类固醇等药物治疗方法提供额外的治疗价值,尤其是在那些具有重度听力损失的案例。使用皮质类固醇(全身和/或非典型性)

Sci Rep:口服咖啡因能够恶化顺铂诱导的听力损失

腺苷A1受体(A1AR)在细胞保护作用中的作用已经研究的很清楚。之前的研究阐释了这些受体在耳蜗中存在,并且它们的激活能够抑制顺铂诱导的炎症反应并导致耳毒性。通过咖啡因来抑制A1AR能够拮抗这些受体在耳蜗中的内源保护性作用,并促进顺铂诱导的听力损失的产生。上述假设在一个顺铂诱导的耳毒性小鼠模型中进行了测试。最近,有研究人员报道了咖啡因单次给药能够恶化顺铂诱导的听力损失,并不会增加对外听毛细胞(OHC

Sci Rep:高钾饮食与听力阈值相关性研究

最近,有研究人员在韩国成年人中确定和评估了高钾摄入饮食与听力阈值之间的关系。研究数据来源于韩国国家健康和营养调查数据,并基于参与者钾的摄入量分成了低、中和高摄入3个组,并且每个组别中均包括了1975名参与者。研究人员发现,在低频(0.5和1kHz)、中频(2和3kHz)、高频(4和6kHz)和0.5到3kHz是的纯音听觉阈值均值在3个钾离子摄入增加的组别中均显著减少。多变量分析阐释了上述4个不同的

Otol Neurotol:感觉神经性听力损失的覆膜异常研究

最近,有研究人员利用组织病理学技术评估了覆膜(TM)连同听毛细胞退化、牙间细胞和内淋巴积水(EH)在感觉神经性听力损失患者中的形态变化情况。TM在声能的机械传导过程中具有重要作用,TM病理能够导致HL。研究人员总共评估了1340名个体的2290例颞骨(TBs)。研究发现,748例来源于耳科疾病的TBs中,164例表现为异常,且符合入选标准。与老年性耳聋(2.9%)案例相比,其中最常见的障碍为特发性

Baidu
map
Baidu
map
Baidu
map